, Health and Social Care Committee
European models of health and social care: evidence session with academics
Do you want to jump in, Jack?
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Ah. Okay.
, Health and Social Care Committee
European models of health and social care: evidence session with academics
It sounds just like Wales except for the weather. [Laughter.]
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Oh, yes. Thank you. Great. Thank you.
, Health and Social Care Committee
European models of health and social care: evidence session with academics
I was going to say I'm trying to make this a free-flowing discussion, so if anybody wants to come in with a quick question, to clarify, then just indicate; I'll bring you in straight away. Jack, do you want to come in now?
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Sorry. Where are these countries, Mark? Sorry.
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Mabon, do you want to come back at all, or carry on with the discussion? No. That's fine. I suppose, from my—. I'm coming to Sarah next now, but, from my perspective, what I would hope to get out of this session today is to see if there are countries' or…
, Health and Social Care Committee
European models of health and social care: evidence session with academics
I was going to add to that, as well, to Mabon's question, in terms of: does it also follow through that the more you spend on health follows through to outcomes as well? Is the chart the same for outcomes and spend?
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Yes. Mabon.
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Mabon wanted to come in as well. Joyce, did you want to—? I'll come back to Mabon and Sarah. Do you want to jump in as well afterwards? Shall I come to Mabon first?
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Thank you, Professor Scott. This is a free-flowing discussion as well, if Members want to indicate to come in. I know, Joyce, Professor Scott just mentioned workforce issues and I know you had some questions around that. Do you want to come in on those now?
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Sure. Before I bring in Professor Scott as well, I think, from my perspective, we're used to, in this committee, comparing Wales to England. It's quite common. But I suppose, in this session this morning, in a wider context, Wales is relatively the same as…
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Thank you, both, and I suppose, in one sense, we as committee members won't expect you to be that familiar with the Welsh health system, because we want to pick your brains on health systems elsewhere across Europe, but, of course, it's helpful that you know…
, Health and Social Care Committee
European models of health and social care: evidence session with academics
And Professor Greer.
, Health and Social Care Committee
European models of health and social care: evidence session with academics
Croeso, pawb—welcome back to the Health and Social Care Committee. I move to item 5, and this session is in regard to that, earlier in the year, the committee agreed to hold a scene-setting session with relevant experts to gain a clearer understanding of…
, Health and Social Care Committee
Motion under Standing Order 17.42 (ix) to resolve to exclude the public for items 4, 7, 8 and 9
I move to item 3, and I propose in accordance with Standing Order 17.42 that the committee resolves to exclude the public for items 4, 7, 8 and 9. Are Members content? Thank you. We'll go into private session and be back in public session at 11.30 a.m.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Okay. Well, that's a clear answer. Thank you. Any other questions from anybody at all? No. Thank you. We rushed through that last session quite quickly. We've had lots of questions today, but thank you, Minister, and I thank your officials for being with us…
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
That's not your knowledge. Okay.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
I suppose it wasn't so much I was trying to draw out a comparison with England. The evidence that was there was that it's taking longer to draw out in Wales than other parts of the UK, but you're saying you don't have—
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Thank you. Can I just pick up on Sarah Murphy's first point, because we had some evidence that new cancer drugs and treatments have taken longer to introduce in Wales than other parts of the UK? The suggestion is it's because funding isn't always available…
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Yes. You had some questions around research and innovation, I think.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Thank you, Jack. Sorry, Sarah. Now, Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Okay—I'll come to Jack next.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Thank you, Joyce. Sarah—Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: evidence session with the Minister for Health and Social Services
Thank you, Sarah. Joyce Watson, you've probably got about five minutes for this section.
